TMC expands regulatory, medical and scientific expertise with acquisition of tranScrip
TMC is pleased to announce that tranScrip, a specialist [...]
Orphan Therapeutics Accelerator Expands its Network to Extend Development and Access Pathways for Ultra-Rare Disease Therapies
CAMBRIDGE, Mass., June 23, 2026 New collaborations add coordinated [...]
TMC announces three specialist service lines to accelerate drug development for biotech and pharma companies
London, UK — 5 November 2025 TMC, a global [...]
TMC secures UK MAH for rare disease product in the United Kingdom
TMC, a global clinical research organisation (CRO) dedicated to [...]
TMC appointed UK marketing authorisation holder to drive rapid commercialisation of rare disease drug
TMC, a global clinical research organisation (CRO) dedicated to [...]
New Board members welcomed to TMC
Last week marked TMC's first Board meeting since our [...]
TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team
Hampshire, UK — 03 June 2024 TMC Pharma Services Ltd., [...]
TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of development
Hampshire, UK — 7 May 2024 TMC Pharma [...]
LDC backs TMC’s international growth plan
03 July 2023 - TMC provides a full range [...]
LDC invests £18m in TMC Pharma Services
24 August 2022 - TMC Pharma Services (TMC) is a [...]